Anyway, clinical evidence shows that IL-23 blockade is less effective than inhibition of IL-17A on improving disease symptoms in the spine, suggesting potential differences between the role of IL-23 in spinal versus peripheral enthesitis [136]. Here, IL17A is linked to enthesitis.